Instruments for measuring medication-induced movement disorders;Meetinstrumenten bij motorische bijwerkingen

Tijdschrift voor Psychiatrie

Volumn 46, Issue 10, 2004, Pages 711-715

  Van Harten, P N ^a  

^a Symfora Groep   (Netherlands)

Author keywords

Adverse effects; Assessment; Movement disorders; Severity

Indexed keywords

CLINICAL PRACTICE; DISEASE SEVERITY; EVALUATION; HUMAN; MENTAL DISEASE; MENTAL TEST; RATING SCALE; REVIEW; SELF REPORT; TRAINING;

EID: 6344266881     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Barnes, T.R. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672-676.
2. Fahn, S. (1989). Assessment of the primary dystonias. In T.L. Munsat (Red.), Quantification of neuroleptic deficit (pp. 241-270). Boston: Butterworths.
3. Gerlach, J., Korsgaard, S., Clemmesen, P., e.a. (1993). The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatrica Scandinavica, 87, 244-252.
4. Guy, W. (1976). ECDEU assessment manual for psychopharmacology. Rockville, Md: US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
5. Harten, P.N. van. (2000). Bewegingsstoornissen door antipsychotica: diagnostiek en behandeling. Amsterdam: Boom.
6. Harten, P.N. van. (2002). Acathisie als bijwerking van geneesmiddelen. Nederlands Tijdschrift voor Geneeskunde, 146, 110-114.
7. Harten, P.N. van. (2003). Acute bewegingsstoornissen door medicijnen. Tijdschrift voor Psychiatrie, 45, 251-263.
8. Harten, P.N. van, Matroos, G.E., Hoek, H.W., e.a. (1996). The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curacao Extrapyramidal Syndromes Study: I. Schizophrenia Research, 19, 195-203.
9. Loonen, A.J., Doorschot, C.H., van Hemert, D.A., e.a. (2000). The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMOD): test-retest reliability and concurrent validity. International Journal of Neuropsychopharmacology, 3, 285-296.
10. Martinez-Martin, P., Gil-Nagel, A., Gracia, L.M., e.a. (1994). Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Movement Disorders, 9, 76-83.
11. Mazure, C.M., Cellar, J.S., Bowers, M.B., Jr., e.a. (1995). Assessment of extrapyramidal symptoms during acute neuroleptic treatment. Journal of Clinical Psychiatry, 56, 94-100.
12. Owens, D.G.C. (1999). A guide to the extrapyramidal side-effects of antipsychotic drugs. New York: Cambridge University Press UK.
13. Schooler, N.R., & Kane, J.M. (1982). Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486-487.
14. Simpson, G.M., & Angus, J.W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212(Suppl.), 11-19.
15. Sweet, RA, DeSensi, E.G., & Zubenko, G.S. (1993). Reliability and applicability of movement disorder rating scales in the elderly. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 56-60.